Literature DB >> 8325712

A role for the fyn oncogene in metastasis of methylcholanthrene-induced fibrosarcoma A cells.

T Takayama1, Y Mogi, K Kogawa, N Yoshizaki, H Muramatsu, K Koike, K Semba, T Yamamoto, Y Niitsu.   

Abstract

Expression of various oncogenes (ras, myc, erbB2, src, fyn, yes and sis) in a high-metastatic clone (MH-02) derived from a murine methylcholanthrene-induced fibrosarcoma A (Meth A) was compared with those of its parent clone (ML-01) by Northern blot analysis. Two oncogenes, fyn, belonging to the tyrosine-kinase family, and sis, belonging to the cellular-growth-factor family, were found to have higher signals (3.6-fold and 1.8-fold respectively) in MH-02 than in ML-01 cells. To explore the possibility that higher expression of these oncogenes is involved in enhanced metastasis of the MH-02 clone, ML-01 was transfected by a fyn vector and the metastatic potential of the transfectant was examined. Mice administered fyn-transfected ML-01 cells had significantly increased metastatic nodules in the lung, as compared with those whose ML-01 cells were transfected with control vector without the fyn gene. The result indicates that the fyn gene is one of the factors governing the metastatic potential of Meth A cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8325712     DOI: 10.1002/ijc.2910540525

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  3 in total

1.  Genome-wide transcriptional analysis of the human cell cycle identifies genes differentially regulated in normal and cancer cells.

Authors:  Ziv Bar-Joseph; Zahava Siegfried; Michael Brandeis; Benedikt Brors; Yong Lu; Roland Eils; Brian D Dynlacht; Itamar Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-14       Impact factor: 11.205

2.  Enhanced expression of type IV collagen-binding protein (p29) in Fyn-transfected murine fibrosarcoma cells.

Authors:  Kazuhiko Koike; Katsuhisa Kogawa; Tetsuji Takayama; Naohito Yoshizaki; Hirohito Muramatsu; Kiminori Nakamura; Sumio Sakamaki; Yoshiro Niitsu
Journal:  Jpn J Cancer Res       Date:  2002-10

3.  Identified the novel resistant biomarkers for taxane-based therapy for triple-negative breast cancer.

Authors:  Ching-Wen Chou; Yu-Min Huang; Yu-Jia Chang; Chien-Yu Huang; Chin-Sheng Hung
Journal:  Int J Med Sci       Date:  2021-04-26       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.